Literature DB >> 15138421

Serum immunoglobulins and IgG subclass levels in sinus mycetoma.

Rong-San Jiang1, Chen-Yi Hsu.   

Abstract

OBJECTIVE: To study the immunity of patients with sinus mycetoma by measuring serum immunoglobulins and IgG subclass levels. STUDY DESIGN AND
SETTING: Thirty patients with sinus mycetoma, 71 ordinary chronic rhinosinusitis patients without nasal polyps, and 77 ordinary chronic rhinosinusitis patients with nasal polyps were collected. In all subjects, the levels of total serum immunoglobulins and IgG subclasses were measured during surgical treatment.
RESULTS: Among 30 patients with sinus mycetoma, decreased IgA level was found in 1 patient, and decreased IgM level was found in another 2 patients. There were no significant differences in the levels of total serum immunoglobulins or IgG subclasses between patients with sinus mycetoma and ordinary chronic rhinosinusitis patients with or without nasal polyps.
CONCLUSION: Immunologic defects cannot be detected in patients with sinus mycetoma by measuring levels of total serum immunoglobulins or IgG subclasses. SIGNIFICANCE: Immunoglobulin deficiency may not play an important role in the pathogenesis of sinus mycetoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138421     DOI: 10.1016/j.otohns.2003.07.014

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  3 in total

1.  Diagnosis and treatment of paranasal sinus fungus ball of odontogenic origin: case report.

Authors:  E Fanucci; M Nezzo; L Neroni; L Montesani; L Ottria; M Gargari
Journal:  Oral Implantol (Rome)       Date:  2014-04-04

Review 2.  Antibody deficiency in chronic rhinosinusitis: epidemiology and burden of illness.

Authors:  Christopher J Ocampo; Anju T Peters
Journal:  Am J Rhinol Allergy       Date:  2013-01       Impact factor: 2.467

Review 3.  Fungus balls of the paranasal sinuses: a review.

Authors:  Pierre Grosjean; Rainer Weber
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-03-15       Impact factor: 3.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.